$QS
QuantumScape Corp

2022 Q2 Form 10-Q Financial Statement

#000095017022013499 Filed on July 29, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $30.74M $29.31M $20.35M
YoY Change 122.01% 92.72% 42.1%
% of Gross Profit
Research & Development $65.13M $61.35M $46.79M
YoY Change 82.06% 108.2% -28.13%
% of Gross Profit
Depreciation & Amortization $5.782M $4.724M $2.162M
YoY Change 64.26% 130.44% -71.21%
% of Gross Profit
Operating Expenses $95.87M $90.66M $67.14M
YoY Change 93.21% 102.93% -15.47%
Operating Profit -$95.87M -$90.66M
YoY Change 93.21% 102.93%
Interest Expense $607.0K $600.0K -$140.0K
YoY Change 155.04% -101.97% -99.29%
% of Operating Profit
Other Income/Expense, Net $1.036M $304.0K $50.00K
YoY Change -99.21% -101.0% -100.01%
Pretax Income -$94.84M -$90.35M -$67.23M
YoY Change -217.1% 20.33% -93.88%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$94.83M -$90.35M -$67.23M
YoY Change -217.09% 20.34% -93.88%
Net Earnings / Revenue
Basic Earnings Per Share -$0.22 -$0.21
Diluted Earnings Per Share -$0.22 -$210.4K -$158.2K
COMMON SHARES
Basic Shares Outstanding 431.5M 95.45M
Diluted Shares Outstanding 431.5M 429.3M

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $422.1M $333.4M $406.8M
YoY Change -15.06% -56.26% 86.25%
Cash & Equivalents $343.4M $283.0M $320.7M
Short-Term Investments $78.70M $50.40M $86.10M
Other Short-Term Assets $10.33M $13.79M $15.76M
YoY Change -2.77% 62.22% 35.84%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $1.278B $1.362B $1.463B
YoY Change -18.99% -11.65% 45.01%
LONG-TERM ASSETS
Property, Plant & Equipment $233.8M $200.7M $166.2M
YoY Change 156.29% 237.2% 280.32%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $18.43M $18.12M $18.23M
YoY Change 50.79% 540.54% 731.46%
Total Long-Term Assets $345.1M $306.8M $252.2M
YoY Change 109.28% 312.35% 337.87%
TOTAL ASSETS
Total Short-Term Assets $1.278B $1.362B $1.463B
Total Long-Term Assets $345.1M $306.8M $252.2M
Total Assets $1.624B $1.669B $1.716B
YoY Change -6.85% 3.26% 60.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.11M $10.12M $14.18M
YoY Change 63.46% 2.55% 163.46%
Accrued Expenses $4.948M $8.823M $6.078M
YoY Change -54.12% 112.09% 81.11%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $461.0K $20.00K $19.00K
YoY Change
Total Short-Term Liabilities $39.82M $28.05M $30.61M
YoY Change 57.55% 31.35% 147.83%
LONG-TERM LIABILITIES
Long-Term Debt $39.34M $39.98M $39.38M
YoY Change 1.62%
Other Long-Term Liabilities $6.855M $5.768M $315.0K
YoY Change -95.99% -98.07% -97.19%
Total Long-Term Liabilities $6.855M $5.768M $315.0K
YoY Change -96.73% -98.07% -97.19%
TOTAL LIABILITIES
Total Short-Term Liabilities $39.82M $28.05M $30.61M
Total Long-Term Liabilities $6.855M $5.768M $315.0K
Total Liabilities $150.8M $132.6M $107.1M
YoY Change -35.83% -58.65% -84.99%
SHAREHOLDERS EQUITY
Retained Earnings -$2.209B -$2.114B -$2.024B
YoY Change 12.02% 2.98% 2.32%
Common Stock $3.699B $3.664B $3.635B
YoY Change 6.33% 9.5% 56.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.471B $1.535B $1.607B
YoY Change
Total Liabilities & Shareholders Equity $1.624B $1.669B $1.716B
YoY Change -6.85% 3.26% 60.83%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q4
OPERATING ACTIVITIES
Net Income -$94.83M -$90.35M -$67.23M
YoY Change -217.09% 20.34% -93.88%
Depreciation, Depletion And Amortization $5.782M $4.724M $2.162M
YoY Change 64.26% 130.44% -71.21%
Cash From Operating Activities -$51.33M -$47.40M -$44.61M
YoY Change 56.05% 120.1% -26.33%
INVESTING ACTIVITIES
Capital Expenditures -$27.63M $39.29M -$44.78M
YoY Change -9.06% 198.56% 85.89%
Acquisitions
YoY Change
Other Investing Activities $135.8M $47.72M $64.21M
YoY Change -134.13% -57.05% -111.71%
Cash From Investing Activities $108.2M $8.427M $19.43M
YoY Change -125.26% -91.39% -103.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.481M 1.287M 6.744M
YoY Change -96.86% -99.78% -99.07%
NET CHANGE
Cash From Operating Activities -51.33M -47.40M -44.61M
Cash From Investing Activities 108.2M 8.427M 19.43M
Cash From Financing Activities 3.481M 1.287M 6.744M
Net Change In Cash 60.35M -37.69M -18.43M
YoY Change -117.22% -105.81% -120.75%
FREE CASH FLOW
Cash From Operating Activities -$51.33M -$47.40M -$44.61M
Capital Expenditures -$27.63M $39.29M -$44.78M
Free Cash Flow -$23.70M -$86.70M $175.0K
YoY Change 844.26% 149.86% -100.48%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Amendment Flag
AmendmentFlag
false
CY2022Q2 qs Number Of Shareholder Derivative Suit Filed
NumberOfShareholderDerivativeSuitFiled
1
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q2 qs Number Of Shareholder Derivative Suit Filed
NumberOfShareholderDerivativeSuitFiled
1
dei Entity Central Index Key
EntityCentralIndexKey
0001811414
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39345
dei Entity Registrant Name
EntityRegistrantName
QUANTUMSCAPE CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-0796578
dei Entity Address Address Line1
EntityAddressAddressLine1
1730 Technology Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
San Jose
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
7442000
qs Net Income Loss Tax Portion Attributable To Noncontrolling Interest
NetIncomeLossTaxPortionAttributableToNoncontrollingInterest
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.43
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95110
dei Security12b Title
Security12bTitle
Class A Common Stock, par value $0.0001 per share
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
dei City Area Code
CityAreaCode
408
dei Local Phone Number
LocalPhoneNumber
452-2000
dei Trading Symbol
TradingSymbol
QS
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
343368000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
320700000
CY2022Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
924752000
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1126975000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10328000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15757000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
1278448000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1463432000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
233778000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
166183000
CY2022Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
29450000
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
30886000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
63494000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
36913000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
18425000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
18234000
CY2022Q2 us-gaap Assets
Assets
1623595000
CY2021Q4 us-gaap Assets
Assets
1715648000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
23105000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
14182000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4948000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6078000
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8724000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9119000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2577000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1209000
CY2022Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
461000
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
19000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
39815000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
30607000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
64753000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
36760000
CY2022Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
39337000
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
39378000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6855000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
315000
CY2022Q2 us-gaap Liabilities
Liabilities
150760000
CY2021Q4 us-gaap Liabilities
Liabilities
107060000
CY2022Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1684000
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1693000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3699039000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3634665000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1250000000
us-gaap Operating Expenses
OperatingExpenses
94297000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-95873000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1250000000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-49622000
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
43000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
43000
us-gaap Operating Income Loss
OperatingIncomeLoss
-186530000
us-gaap Operating Income Loss
OperatingIncomeLoss
-94297000
CY2022Q2 us-gaap Interest Expense
InterestExpense
607000
us-gaap Profit Loss
ProfitLoss
-185190000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-19145000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4208000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2208786000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2023605000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1471151000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1606895000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1623595000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1715648000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
65133000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
35776000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
126478000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
65241000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
30740000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13846000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
60052000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
29056000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
95873000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
49622000
us-gaap Operating Expenses
OperatingExpenses
186530000
CY2021Q2 us-gaap Interest Expense
InterestExpense
238000
us-gaap Interest Expense
InterestExpense
1207000
us-gaap Interest Expense
InterestExpense
238000
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1510000
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
349000
us-gaap Investment Income Interest
InvestmentIncomeInterest
2326000
us-gaap Investment Income Interest
InvestmentIncomeInterest
596000
CY2021Q2 qs Change In Fair Value Of Assumed Common Stock Warrant Liabilities
ChangeInFairValueOfAssumedCommonStockWarrantLiabilities
-130504000
qs Change In Fair Value Of Assumed Common Stock Warrant Liabilities
ChangeInFairValueOfAssumedCommonStockWarrantLiabilities
-99740000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
133000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
221000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
98000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1036000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
130610000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1340000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
100196000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-94837000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
80988000
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-8000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-9000
us-gaap Profit Loss
ProfitLoss
5899000
CY2022Q2 qs Net Income Loss Tax Portion Attributable To Noncontrolling Interest
NetIncomeLossTaxPortionAttributableToNoncontrollingInterest
0
qs Net Income Loss Tax Portion Attributable To Noncontrolling Interest
NetIncomeLossTaxPortionAttributableToNoncontrollingInterest
0
CY2021Q2 qs Net Income Loss Tax Portion Attributable To Noncontrolling Interest
NetIncomeLossTaxPortionAttributableToNoncontrollingInterest
0
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-10000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-94829000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
80988000
us-gaap Net Income Loss
NetIncomeLoss
-185181000
us-gaap Net Income Loss
NetIncomeLoss
5909000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-94837000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
80988000
us-gaap Profit Loss
ProfitLoss
-185190000
us-gaap Profit Loss
ProfitLoss
5899000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3321000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-837000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-14937000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-663000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-98158000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
80151000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-200127000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
5236000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-8000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-9000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-10000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-98150000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
80151000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-200118000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5246000
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.43
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
431523000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
404957000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
430435000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
386970000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
431523000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
410372000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
430435000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
396059000
CY2022Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1692000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1534695000
CY2022Q2 qs Stock Issued During Period Value Stock Options And Employee Stock Purchase Plan Exercised
StockIssuedDuringPeriodValueStockOptionsAndEmployeeStockPurchasePlanExercised
3680000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
30926000
CY2022Q2 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
-8000
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1693000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-94829000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3321000
CY2021Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1694000
CY2022Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1684000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1471151000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1506431000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-804000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-98733000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1606895000
qs Stock Issued During Period Value Stock Options And Employee Stock Purchase Plan Exercised
StockIssuedDuringPeriodValueStockOptionsAndEmployeeStockPurchasePlanExercised
4967000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
59407000
us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
-9000
us-gaap Net Income Loss
NetIncomeLoss
-185181000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-14937000
CY2022Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1684000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1471151000
CY2021Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1694000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1293906000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8572000
CY2021Q2 qs Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
12265000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11607000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
80988000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-837000
CY2021Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1694000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1506431000
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1704000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
351772000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9452000
qs Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
553822000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
23283000
us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
-10000
us-gaap Net Income Loss
NetIncomeLoss
5909000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-663000
us-gaap Profit Loss
ProfitLoss
-185190000
us-gaap Profit Loss
ProfitLoss
5899000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10506000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4853000
qs Operating And Finance Lease Amortization Of Right Of Use Asset And Non Cash Lease Expense
OperatingAndFinanceLeaseAmortizationOfRightOfUseAssetAndNonCashLeaseExpense
3698000
qs Operating And Finance Lease Amortization Of Right Of Use Asset And Non Cash Lease Expense
OperatingAndFinanceLeaseAmortizationOfRightOfUseAssetAndNonCashLeaseExpense
1271000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-3713000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-5432000
us-gaap Share Based Compensation
ShareBasedCompensation
59407000
us-gaap Share Based Compensation
ShareBasedCompensation
23283000
qs Change In Fair Value Of Assumed Common Stock Warrant Liabilities
ChangeInFairValueOfAssumedCommonStockWarrantLiabilities
-99740000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-608000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
113000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-5238000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-468000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
701000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5016000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
2100000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
486000
us-gaap Interest Paid Net
InterestPaidNet
607000
us-gaap Interest Paid Net
InterestPaidNet
238000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
17871000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-54435000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
66925000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
43655000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
419240000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
411000000
qs Proceeds From Sales Of Marketable Securities
ProceedsFromSalesOfMarketableSecurities
15105000
qs Proceeds From Sales Of Marketable Securities
ProceedsFromSalesOfMarketableSecurities
121455000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
250787000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
819339000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
116633000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-330539000
qs Proceeds From Exercise Of Stock Options And Employee Stock Purchase Plan
ProceedsFromExerciseOfStockOptionsAndEmployeeStockPurchasePlan
4967000
qs Proceeds From Exercise Of Stock Options And Employee Stock Purchase Plan
ProceedsFromExerciseOfStockOptionsAndEmployeeStockPurchasePlan
9452000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
112318000
qs Payment Of Business Combination Share Issuance Costs
PaymentOfBusinessCombinationShareIssuanceCosts
1016000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
462926000
qs Proceeds From Issuance Of Class A Common Stock Pursuant To Legacy Quantum Scape Series F Preferred Stock Purchase Agreement Net Of Issuance Costs
ProceedsFromIssuanceOfClassACommonStockPursuantToLegacyQuantumScapeSeriesFPreferredStockPurchaseAgreementNetOfIssuanceCosts
99930000
qs Principal Payments For Finance Lease Net Of Credit
PrincipalPaymentsForFinanceLeaseNetOfCredit
199000
qs Principal Payments For Finance Lease Net Of Credit
PrincipalPaymentsForFinanceLeaseNetOfCredit
-38000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4768000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
683648000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
22668000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
298674000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
338223000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
115410000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
360891000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
414084000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
13090000
qs Fair Value Of Assumed Common Stock Warrants Exercised
FairValueOfAssumedCommonStockWarrantsExercised
441504000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
343368000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
402391000
CY2022Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
17523000
CY2021Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
11693000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
360891000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
414084000
CY2022Q2 qs Goodwill Or Other Intangible Assets
GoodwillOrOtherIntangibleAssets
0
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of commitments and contingencies at the date of the financial statements as well as reported amounts of expenses during the reporting periods. Estimates made by the Company include, but are not limited to, those related to the valuation of common stock prior to the Business Combination, valuation of awards under the Extraordinary Performance Award Program (the “EPA Program”), and valuation of Assumed Common Stock Warrants among others. The Company bases these estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from those estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2018Q3 qs Number Of Operating Agreements Of Joint Venture Parties
NumberOfOperatingAgreementsOfJointVentureParties
2
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Concentrations of Credit Risk</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments that potentially subject the Company to credit risk consist principally of cash and cash equivalents and marketable securities. As of June 30, 2022 and December 31, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">232.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">227.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million of our total cash and cash equivalents and marketable securities are held in U.S. money market funds, and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">626.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">722.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million are invested in U.S. government and agency securities, respectively. The Company seeks to mitigate its credit risk with respect to cash and cash equivalents and marketable securities by making deposits with large, reputable financial institutions and investing in high credit rated shorter-term instruments.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2022Q2 us-gaap Restricted Cash
RestrictedCash
17500000
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
17500000
CY2022Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2021Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2022Q2 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
5000
CY2021Q2 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
17011000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
957702000
CY2021Q4 qs Area Of Rentable Space Lease
AreaOfRentableSpaceLease
222000
CY2021Q4 qs Lessee Operating Lease Extension Of Lease Term Month And Year
LesseeOperatingLeaseExtensionOfLeaseTermMonthAndYear
2032-09
CY2022Q2 us-gaap Marketable Securities
MarketableSecurities
78700000
CY2021Q4 us-gaap Marketable Securities
MarketableSecurities
86100000
CY2022Q2 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
0
CY2021Q4 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
0
qs Number Of Marketable Securities
NumberOfMarketableSecurities
107
CY2021 qs Number Of Marketable Securities
NumberOfMarketableSecurities
118
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
8120000
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
437891000
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
11025000
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
397515000
CY2022Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
19145000
CY2022Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
835406000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
4203000
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
4208000
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
974713000
CY2022Q2 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
2000000.0
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
15200000
CY2021Q2 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
122300000
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
122300000
CY2022Q2 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2021Q4 us-gaap Lessee Finance Lease Existence Of Option To Extend
LesseeFinanceLeaseExistenceOfOptionToExtend
true
CY2021Q4 us-gaap Lessee Finance Lease Option To Extend
LesseeFinanceLeaseOptionToExtend
10-year
CY2021Q2 us-gaap Lessee Finance Lease Renewal Term1
LesseeFinanceLeaseRenewalTerm1
P5Y
CY2021Q2 us-gaap Lessee Finance Lease Existence Of Option To Extend
LesseeFinanceLeaseExistenceOfOptionToExtend
true
CY2022Q2 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
941101000
CY2022Q2 us-gaap Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
934995000
CY2022Q2 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
317758000
CY2022Q2 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
304720000
CY2022Q2 us-gaap Held To Maturity Securities Debt Maturities Single Maturity Date Amortized Cost Basis
HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
1258859000
CY2022Q2 us-gaap Held To Maturity Securities Debt Maturities Single Maturity Date Fair Value
HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue
1239715000
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
286769000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
209421000
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
52991000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
43238000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
233778000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
166183000
CY2022Q2 qs Depreciation And Amortization Of Property And Equipment
DepreciationAndAmortizationOfPropertyAndEquipment
5500000
CY2021Q2 qs Depreciation And Amortization Of Property And Equipment
DepreciationAndAmortizationOfPropertyAndEquipment
3000000.0
qs Depreciation And Amortization Of Property And Equipment
DepreciationAndAmortizationOfPropertyAndEquipment
10300000
qs Depreciation And Amortization Of Property And Equipment
DepreciationAndAmortizationOfPropertyAndEquipment
5200000
CY2022Q2 qs Long Term Advance Payments
LongTermAdvancePayments
2415000
CY2021Q4 qs Long Term Advance Payments
LongTermAdvancePayments
315000
CY2022Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
4440000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6855000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
315000
qs Lessee Operating Lease Expiration Year
LesseeOperatingLeaseExpirationYear
2032
CY2021Q2 qs Area Of Rentable Space Lease
AreaOfRentableSpaceLease
197000
CY2021Q2 qs Lessee Operating Lease Extension Of Lease Term Month And Year
LesseeOperatingLeaseExtensionOfLeaseTermMonthAndYear
2032-09
CY2021Q2 qs Number Of Finance Lease Renewal Options
NumberOfFinanceLeaseRenewalOptions
2
CY2021Q2 qs Lessee Operating Lease Extension Of Lease Term Month And Year
LesseeOperatingLeaseExtensionOfLeaseTermMonthAndYear
2032-09
CY2022Q2 qs Finance Lease Liability Payments Net Of Reimbursements Due Next Twelve Months
FinanceLeaseLiabilityPaymentsNetOfReimbursementsDueNextTwelveMonths
3751000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
8872000
CY2021Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3466000
us-gaap Lessee Operating Lease Lease Not Yet Commenced Description
LesseeOperatingLeaseLeaseNotYetCommencedDescription
The November 2021 leases commenced in November 2021, January 2022, and April 2022 and were classified as operating leases. The additional 10-year extension period has not been included in the calculation of the lease liability and right-of use asset at the lease inception as the exercise of the option was not reasonably certain.
CY2022Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
718000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1437000
CY2022Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
607000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1207000
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
2241000
us-gaap Operating Lease Cost
OperatingLeaseCost
4258000
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
726000
us-gaap Variable Lease Cost
VariableLeaseCost
1133000
CY2022Q2 us-gaap Lease Cost
LeaseCost
4292000
us-gaap Lease Cost
LeaseCost
8035000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
607000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
199000
us-gaap Operating Lease Payments
OperatingLeasePayments
1203000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
28845000
CY2022Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P10Y3M
CY2022Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0606
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y1M6D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0636
CY2022Q2 qs Finance Lease Liability Payments Net Of Reimbursements Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsNetOfReimbursementsRemainderOfFiscalYear
1613000
CY2022Q2 qs Shares Authorized
SharesAuthorized
1350000000
CY2022Q2 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
3189000
CY2022Q2 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
2356000
CY2022Q2 qs Finance Lease Liability Payments Net Of Reimbursements Due Year Two
FinanceLeaseLiabilityPaymentsNetOfReimbursementsDueYearTwo
5131000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
9085000
CY2022Q2 qs Finance Lease Liability Payments Net Of Reimbursements Due Year Three
FinanceLeaseLiabilityPaymentsNetOfReimbursementsDueYearThree
5272000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
9033000
CY2022Q2 qs Finance Lease Liability Payments Net Of Reimbursements Due Year Four
FinanceLeaseLiabilityPaymentsNetOfReimbursementsDueYearFour
5417000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
9135000
CY2022Q2 qs Finance Lease Liability Payments Net Of Reimbursements Due Year Five
FinanceLeaseLiabilityPaymentsNetOfReimbursementsDueYearFive
5566000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
46370000
CY2022Q2 qs Finance Lease Liability Payments Net Of Reimbursements Due After Year Five
FinanceLeaseLiabilityPaymentsNetOfReimbursementsDueAfterYearFive
28066000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
93403000
CY2022Q2 qs Finance Lease Liability Payments Net Of Reimbursements Due
FinanceLeaseLiabilityPaymentsNetOfReimbursementsDue
54816000
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
26073000
CY2022Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
15018000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
67330000
CY2022Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
39798000
CY2021Q1 qs Number Of Shareholder Derivative Suit Filed
NumberOfShareholderDerivativeSuitFiled
2
CY2021Q1 qs Number Of Officers And Directors In Shareholder Derivative Suit
NumberOfOfficersAndDirectorsInShareholderDerivativeSuit
11
CY2022Q2 qs Number Of Officers And Directors In Shareholder Derivative Suit
NumberOfOfficersAndDirectorsInShareholderDerivativeSuit
12
CY2022Q2 qs Number Of Officers And Directors In Shareholder Derivative Suit
NumberOfOfficersAndDirectorsInShareholderDerivativeSuit
15
us-gaap Other Commitments Description
OtherCommitmentsDescription
The Company's minimum purchase commitments consist of non-cancellable agreements to purchase goods and services, primarily for materials, and licenses and hosting services, entered into in the ordinary course of business.
CY2022Q2 us-gaap Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
908000
CY2022Q2 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
2748000
CY2022Q2 us-gaap Purchase Obligation Due In Fourth Year
PurchaseObligationDueInFourthYear
1890000
CY2022Q2 us-gaap Purchase Obligation Due In Fifth Year
PurchaseObligationDueInFifthYear
1181000
CY2022Q2 us-gaap Purchase Obligation
PurchaseObligation
12272000
CY2021Q4 qs Shares Authorized
SharesAuthorized
1350000000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2021Q2 qs Change In Fair Value Of Assumed Common Stock Warrant Liabilities
ChangeInFairValueOfAssumedCommonStockWarrantLiabilities
-130500000
qs Change In Fair Value Of Assumed Common Stock Warrant Liabilities
ChangeInFairValueOfAssumedCommonStockWarrantLiabilities
-99700000
us-gaap Common Stock Voting Rights
CommonStockVotingRights
The holder of each share of Class A Common Stock is entitled to one vote, and the holder of each share of Class B Common Stock is entitled to ten votes.
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
53078000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.74
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y9M10D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
929000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
21.06
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1825000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.50
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
50324000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.72
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y3M21D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
251943000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
42010000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.69
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y8M4D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
251943000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
31281000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.63
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y8M15D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
224652000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
23900000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
330000.0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
10000000.0
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y11M26D
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
23283000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
33700000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
135700000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
30926000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11607000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
59407000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-94829000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
80988000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-185181000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5909000
CY2021Q2 qs Change In Fair Value Of Assumed Common Stock Warrant Liabilities
ChangeInFairValueOfAssumedCommonStockWarrantLiabilities
-130504000
qs Change In Fair Value Of Assumed Common Stock Warrant Liabilities
ChangeInFairValueOfAssumedCommonStockWarrantLiabilities
-99740000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-94829000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-49516000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-185181000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-93831000
CY2021Q2 qs Effect Of Dilutive Shares
EffectOfDilutiveShares
5415000
qs Effect Of Dilutive Shares
EffectOfDilutiveShares
9089000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
66607000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
55744000
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1693000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-9000
CY2022Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1684000
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1704000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-10000
CY2021Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1694000

Files In Submission

Name View Source Status
0000950170-22-013499-index-headers.html Edgar Link pending
0000950170-22-013499-index.html Edgar Link pending
0000950170-22-013499.txt Edgar Link pending
0000950170-22-013499-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
qs-20220630.htm Edgar Link pending
qs-20220630.xsd Edgar Link pending
qs-20220630_cal.xml Edgar Link unprocessable
qs-20220630_def.xml Edgar Link unprocessable
qs-20220630_htm.xml Edgar Link completed
qs-20220630_lab.xml Edgar Link unprocessable
qs-20220630_pre.xml Edgar Link unprocessable
qs-ex10_2.htm Edgar Link pending
qs-ex10_3.htm Edgar Link pending
qs-ex31_1.htm Edgar Link pending
qs-ex31_2.htm Edgar Link pending
qs-ex32_1.htm Edgar Link pending
qs-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending